{"id":"https://openalex.org/W2899212912","doi":"https://doi.org/10.1097/cmr.0000000000000543","title":"Mycophenolate mofetil alongside high-dose corticosteroids: optimizing the management of combination immune checkpoint inhibitor-induced colitis","display_name":"Mycophenolate mofetil alongside high-dose corticosteroids: optimizing the management of combination immune checkpoint inhibitor-induced colitis","publication_year":2018,"publication_date":"2018-11-03","ids":{"openalex":"https://openalex.org/W2899212912","doi":"https://doi.org/10.1097/cmr.0000000000000543","mag":"2899212912","pmid":"https://pubmed.ncbi.nlm.nih.gov/30395075"},"language":"en","primary_location":{"id":"doi:10.1097/cmr.0000000000000543","doi":"https://doi.org/10.1097/cmr.0000000000000543","is_oa":false,"landing_page_url":"https://doi.org/10.1097/cmr.0000000000000543","pdf_url":null,"source":{"id":"https://openalex.org/S3207524","display_name":"Melanoma Research","issn_l":"0960-8931","issn":["0960-8931","1473-5636"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Melanoma Research","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5062027183","display_name":"Romaana Mir","orcid":"https://orcid.org/0000-0002-2807-4525","observed_orcids":["https://orcid.org/0000-0002-2807-4525"]},"institutions":[{"id":"https://openalex.org/I4210108939","display_name":"Mount Vernon Cancer Centre","ror":"https://ror.org/01wwv4x50","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210108939","https://openalex.org/I4210122718"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"Romaana Mir","raw_affiliation_strings":["The Clock Tower, Mount Vernon Cancer Centre, Northwood, UK","e-mail: [email\u00a0protected]","to Romaana Mir, MB ChB, MSc, MRCP, FRCR, The Clock Tower, Mount Vernon Cancer Centre, Rickmansworth Road, Northwood, HA6 2RN, UK Tel: +44 203 826 2444"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Clock Tower, Mount Vernon Cancer Centre, Northwood, UK","institution_ids":["https://openalex.org/I4210108939"]},{"raw_affiliation_string":"e-mail: [email\u00a0protected]","institution_ids":[]},{"raw_affiliation_string":"to Romaana Mir, MB ChB, MSc, MRCP, FRCR, The Clock Tower, Mount Vernon Cancer Centre, Rickmansworth Road, Northwood, HA6 2RN, UK Tel: +44 203 826 2444","institution_ids":["https://openalex.org/I4210108939"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103032196","display_name":"Heather May Shaw","orcid":"https://orcid.org/0000-0002-6545-2927","observed_orcids":["https://orcid.org/0000-0002-6545-2927","https://orcid.org/0009-0005-1092-0278"]},"institutions":[{"id":"https://openalex.org/I4210108939","display_name":"Mount Vernon Cancer Centre","ror":"https://ror.org/01wwv4x50","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210108939","https://openalex.org/I4210122718"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Heather M. Shaw","raw_affiliation_strings":["The Clock Tower, Mount Vernon Cancer Centre, Northwood, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Clock Tower, Mount Vernon Cancer Centre, Northwood, UK","institution_ids":["https://openalex.org/I4210108939"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5085499539","display_name":"Paul Nathan","orcid":"https://orcid.org/0000-0002-2327-3250","observed_orcids":["https://orcid.org/0000-0002-2327-3250","https://orcid.org/0000-0002-5612-8439"]},"institutions":[{"id":"https://openalex.org/I4210108939","display_name":"Mount Vernon Cancer Centre","ror":"https://ror.org/01wwv4x50","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210108939","https://openalex.org/I4210122718"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Paul D. Nathan","raw_affiliation_strings":["The Clock Tower, Mount Vernon Cancer Centre, Northwood, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Clock Tower, Mount Vernon Cancer Centre, Northwood, UK","institution_ids":["https://openalex.org/I4210108939"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5062027183"],"corresponding_institution_ids":["https://openalex.org/I4210108939"],"apc_list":null,"apc_paid":null,"fwci":1.3563,"has_fulltext":false,"cited_by_count":32,"citation_normalized_percentile":{"value":0.83278873,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"29","issue":"1","first_page":"102","last_page":"106"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10134","display_name":"Inflammatory Bowel Disease","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2715","display_name":"Gastroenterology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T14072","display_name":"Immunotoxicology and immune responses","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitor-induced-colitis","display_name":"immune checkpoint inhibitor-induced colitis","score":0.925000011920929},{"id":"https://openalex.org/keywords/mycophenolate-mofetil","display_name":"mycophenolate mofetil","score":0.9990000128746033},{"id":"https://openalex.org/keywords/high-dose-corticosteroids","display_name":"high-dose corticosteroids","score":0.9860000014305115},{"id":"https://openalex.org/keywords/corticosteroid-weaning","display_name":"corticosteroid weaning","score":0.8029999732971191},{"id":"https://openalex.org/keywords/metastatic-melanoma","display_name":"metastatic melanoma","score":0.7929999828338623},{"id":"https://openalex.org/keywords/infliximab","display_name":"infliximab","score":0.9010000228881836},{"id":"https://openalex.org/keywords/immunosuppressive-therapy","display_name":"immunosuppressive therapy","score":0.625}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8579460382461548},{"id":"https://openalex.org/C2775862500","wikidata":"https://www.wikidata.org/wiki/Q2453464","display_name":"Colitis","level":2,"score":0.7714911103248596},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.6889874935150146},{"id":"https://openalex.org/C2778715236","wikidata":"https://www.wikidata.org/wiki/Q55622662","display_name":"Discontinuation","level":2,"score":0.6796385645866394},{"id":"https://openalex.org/C2780479503","wikidata":"https://www.wikidata.org/wiki/Q1477","display_name":"Ulcerative colitis","level":3,"score":0.584553062915802},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5394980907440186},{"id":"https://openalex.org/C2776804153","wikidata":"https://www.wikidata.org/wiki/Q210420","display_name":"Corticosteroid","level":2,"score":0.5295729637145996},{"id":"https://openalex.org/C2777138892","wikidata":"https://www.wikidata.org/wiki/Q415264","display_name":"Infliximab","level":3,"score":0.4518600404262543},{"id":"https://openalex.org/C2778260677","wikidata":"https://www.wikidata.org/wiki/Q917447","display_name":"Inflammatory bowel disease","level":3,"score":0.41334787011146545},{"id":"https://openalex.org/C17991360","wikidata":"https://www.wikidata.org/wiki/Q21173843","display_name":"Tumor necrosis factor alpha","level":2,"score":0.09718102216720581},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000074324","descriptor_name":"Ipilimumab","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000077594","descriptor_name":"Nivolumab","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000305","descriptor_name":"Adrenal Cortex Hormones","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000903","descriptor_name":"Antibiotics, Antineoplastic","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D003092","descriptor_name":"Colitis","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D003092","descriptor_name":"Colitis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005500","descriptor_name":"Follow-Up Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008545","descriptor_name":"Melanoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008545","descriptor_name":"Melanoma","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009173","descriptor_name":"Mycophenolic Acid","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D011379","descriptor_name":"Prognosis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011446","descriptor_name":"Prospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012878","descriptor_name":"Skin Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D012878","descriptor_name":"Skin Neoplasms","qualifier_ui":"Q000556","qualifier_name":"secondary","is_major_topic":false},{"descriptor_ui":"D019468","descriptor_name":"Disease Management","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1097/cmr.0000000000000543","doi":"https://doi.org/10.1097/cmr.0000000000000543","is_oa":false,"landing_page_url":"https://doi.org/10.1097/cmr.0000000000000543","pdf_url":null,"source":{"id":"https://openalex.org/S3207524","display_name":"Melanoma Research","issn_l":"0960-8931","issn":["0960-8931","1473-5636"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Melanoma Research","raw_type":"journal-article"},{"id":"pmid:30395075","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/30395075","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Melanoma research","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":13,"referenced_works":["https://openalex.org/W1983509391","https://openalex.org/W1993619878","https://openalex.org/W1994502792","https://openalex.org/W2006091295","https://openalex.org/W2030612376","https://openalex.org/W2044974855","https://openalex.org/W2061904336","https://openalex.org/W2105057287","https://openalex.org/W2117692326","https://openalex.org/W2551653151","https://openalex.org/W2600612550","https://openalex.org/W2736166064","https://openalex.org/W2892119221"],"related_works":["https://openalex.org/W7131349650","https://openalex.org/W4412978619","https://openalex.org/W4296522698","https://openalex.org/W3096913679","https://openalex.org/W2996741718","https://openalex.org/W3168143166","https://openalex.org/W2931644395","https://openalex.org/W2891098684","https://openalex.org/W3136792316","https://openalex.org/W3041834813"],"abstract_inverted_index":{"Immune":[0],"checkpoint":[1],"inhibitor":[2],"(IO)":[3],"induced":[4],"colitis":[5,85,105,167,182,200,220,230],"is":[6,40],"primarily":[7],"managed":[8,87,132],"with":[9,82,88,133],"corticosteroids.":[10,99],"Most":[11],"patients":[12,73,124,178,188],"have":[13],"a":[14,89,158,197],"rapid":[15],"resolution":[16],"of":[17,35,43,64,69,104,136,153,160,199,206,218,229],"symptoms":[18],"and":[19,53,78,118,139,194,225],"do":[20],"not":[21,180],"require":[22,28],"additional":[23],"immunosuppressants.":[24],"Many":[25],"patients,":[26],"however,":[27],"prolonged":[29],"corticosteroid":[30,121,138,185],"courses":[31],"to":[32,59,108,113,171,221],"maintain":[33],"control":[34],"toxicity.":[36],"Mycophenolate":[37],"mofetil":[38],"(MMF)":[39],"the":[41,134,216,227],"prodrug":[42],"mycophenolic":[44],"acid;":[45],"which":[46],"in":[47,57],"turn":[48],"directly":[49],"inhibits":[50],"activated":[51],"T":[52],"B":[54],"lymphocytes.":[55],"MMF,":[56],"addition":[58],"corticosteroids,":[60],"may":[61,214],"enable":[62],"reduction":[63],"corticosteroids":[65,193,213],"without":[66],"precipitating":[67],"resurgence":[68,198],"colitis.":[70],"Metastatic":[71],"melanoma":[72],"between":[74],"1":[75,110],"January":[76],"2017":[77,81],"31":[79],"December":[80],"combination":[83,127,135],"IO-induced":[84,128],"were":[86,131,189],"novel":[90],"treatment":[91],"algorithm:":[92],"upfront":[93],"oral":[94],"enteric-coated":[95,209],"MMF":[96,210],"alongside":[97,211],"high-dose":[98,137,212],"Outcome":[100],"measures":[101],"included":[102],"incidence":[103,228],"flare,":[106],"time":[107,112],"grade":[109],"colitis,":[111],"patient-reported":[114],"normal":[115,222],"bowel":[116,223],"habit":[117,224],"overall":[119],"cumulative":[120],"exposure.":[122],"Thirteen":[123],"developed":[125,151],"high-grade":[126,219],"colitis;":[129,154],"11":[130,161],"MMF.":[140,207],"Median":[141],"patient":[142],"age":[143],"was":[144],"59":[145],"(range:":[146],"28-73)":[147],"years.":[148],"Four":[149],"(36%)":[150],"flare":[152,183],"flares":[155,168],"occurred":[156],"at":[157,201],"median":[159],"(interquartile":[162],"range:":[163],"4.5-16.75)":[164],"days.":[165],"All":[166,187],"responded":[169],"fully":[170],"infliximab":[172],"(5":[173],"mg/kg).":[174],"The":[175],"remaining":[176],"seven":[177],"did":[179],"develop":[181],"during":[184],"wean.":[186],"successfully":[190],"weaned":[191],"from":[192],"none":[195],"had":[196],"8":[202],"weeks":[203],"following":[204],"discontinuation":[205],"Concomitant":[208],"hasten":[215],"improvement":[217],"reduce":[226],"flare.":[231]},"counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":5},{"year":2024,"cited_by_count":5},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":6},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":1}],"updated_date":"2026-11-08T12:12:28.789561","created_date":"2018-11-09T00:00:00"}